PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.4600
+0.0178 (4.03%)
At close: Aug 13, 2025, 4:00 PM
0.4500
-0.0100 (-2.17%)
Pre-market: Aug 14, 2025, 8:54 AM EDT
PAVmed Employees
PAVmed had 39 employees as of December 31, 2024. The number of employees decreased by 68 or -63.55% compared to the previous year.
Employees
39
Change (1Y)
-68
Growth (1Y)
-63.55%
Revenue / Employee
$51,103
Profits / Employee
$1,857,667
Market Cap
8.10M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PAVM News
- 1 hour ago - PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results - PRNewsWire
- 1 day ago - Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results - PRNewsWire
- 9 days ago - Lucid Diagnostics to Participate in Upcoming Investor Conferences - PRNewsWire
- 14 days ago - PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025 - PRNewsWire
- 15 days ago - Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 - PRNewsWire
- 15 days ago - PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule - PRNewsWire
- 4 weeks ago - MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test - PRNewsWire
- 7 weeks ago - PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing - PRNewsWire